Atrility’s Atrial Arrhythmia Monitor Cleared

October 8, 2020

The FDA has granted 510(k) marketing clearance to Atrility Medical, a University of Wisconsin – Madison spinoff company, for its AtriAmp bedside device that helps monitor patients for atrial arrhythmias.

The device uses existing bedside equipment to continuously display an atrial electrogram, an intensive care unit tool that diagnoses arrhythmias in patients who have undergone heart surgery.

The early diagnosis of post-operative arrhythmias leads to better outcomes for patients, says the device’s principal inventor, Nicholas Von Bergen, director of the pediatric electrophysiology lab at the university’s American Family Children's Hospital.

View today's stories